The role of neutrophils in the pathogenesis of idiopathic pulmonary fibrosis

Chest

Volumn 112, Issue 5, 1997, Pages 1338-1343

  Obayashi, Yuka ^b   Yamadori, Ichiro ^b   Fujita, Jiro ^a   Yoshinouchi, Takeo ^b   Ueda, Nobuo ^b   Takahara, Jiro ^b  

^a KAGAWA UNIVERSITY   (Japan)

^b NONE

Author keywords

Idiopathic pulmonary fibrosis; Immunohistochemistry for neutrophil elastase; Neutrophil elastase

Indexed keywords

ALBUMIN; ALPHA 1 ANTITRYPSIN; ENZYME ANTIBODY; LEUKOCYTE ELASTASE; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; LEUKOCYTE COUNT; LUNG FIBROSIS; LUNG LAVAGE; MALE; NEUTROPHIL; OPEN LUNG BIOPSY; PATHOGENESIS; PRIORITY JOURNAL; SMOKING;

EID: 0030694282     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.112.5.1338     Document Type: Article

References (26)

1. Crystal RG, Bitterman PB, Rennard SI, et al. Interstitial lung diseases of unknown cause: disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med 1984; 310:154-66
2. Panos RJ, King TE Jr. Idiopathic pulmonary fibrosis. In: Lynch JP III, DeRemee RA, eds. Immunologically mediated pulmonary diseases. Philadelphia: JB Lippincott, 1991; 1-39
3. The BAL Cooperative Steering Committee. Bronchoalveolar lavage fluid and venous blood constituents in idiopathic pulmonary fibrosis and selected comparison groups. Am Rev Respir Dis 1990; 141:S188-92
4. Turner-Warwick M, Haslam PL. The value of serial bronchoalveolar lavages in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis. Am Rev Respir Dis 1987; 135:26-34
5. Haslam PL, Turton CWG, Lukoszek A, et al. Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy. Thorax 1980; 35:328-29
6. Rudd RM, Haslam PL, Turner-Warwick M. Cryptogenic fibrosing alveolitis: relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis. Am Rev Respir Dis 1981; 124:1-8
7. Hallgren R, Bjermer L, Lundgren R, et al. The eosinophil component of the alveolitis in idiopathic pulmonary fibrosis. Am Rev Respir Dis 1989; 139:373-77
8. Watters LC, Schwartz MI, Cherniack RM, et al. Idiopathic pulmonary fibrosis: pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy. Am Rev Respir Dis 1987; 135:696-704
9. Hunninghake GW, Kawanami O, Ferrans VJ, et al. Characterization of the inflammatory and immune effector cells in the lung parenchyma of patients with interstitial lung disease. Am Rev Respir Dis 1981; 123:407-21
10. Schwartz DA, Helmers RA, Galvin JR, et al. Determinants of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1994; 149:450-54
11. Schwartz DA, Van Fossen DS, Davis CS, et al. Determinants of progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1994; 149:444-49
12. Raghu G. Interstitial lung disease: a diagnostic approach: are CT scan and lung biopsy indicated in every patient? Am J Respir Crit Care Med 1995; 151:909-14
13. Peterson MW, Monick M, Hunninghake GW. Prognostic role of eosinophils in pulmonary fibrosis. Chest 1987; 92:51-56
14. Boomarrs KA, Wagenaar SS, Mulder PGH, et al. Relationship between cells obtained by bronchoalveolar lavage and survival in idiopathic pulmonary fibrosis. Thorax 1995; 50:1087-92
15. Muller NL, Miller RR, Webb WR, et al. Fibrosing alveolitis: CT-pathologic correlation. Radiology 1986; 160:585-88
16. Staples CA, Muller NL, Vedal S, et al. Usual interstitial pneumonia, correlation of CT with clinical, functional, and radiologic findings. Radiology 1987; 162:377-81
17. Hinson KFW, Path FRC. Diffuse pulmonary fibrosis. Hum Pathol 1970; 1:275-88
18. Carrington CB, Gaensler EA, Mikus JP, et al. Structure and function in sarcoidosis. Ann NY Acad Sci 1976; 278:265-83
19. Spencer H. Pathology of the lung. New York: Pergamon Press, 1977
20. Lynch JP III, Standiford TJ, Rolfe MW, et al. Neutrophilic alveolitis in idiopathic pulmonary fibrosis. Am Rev Respir Dis 1992; 145:1433-39
21. Ozaki T, Hayashi H, Tani K, et al. Neutrophil chemotactic factors in the respiratory tract of patients with chronic airway diseases or idiopathic pulmonary fibrosis. Am Rev Respir Dis 1992; 145:85-91
22. Simon RH, Dehart PD, Todd RF. Neutrophil-induced injury of rat pulmonary alveolar epithelial cells. J Clin Invest 1986; 78:1375-86
23. Okrent DG, Lichtenstein AK, Ganz T. Direct cytotoxicity of polymorphonuclear leukocyte granule proteins to human lung-derived cells and endothelial cells. Am Rev Respir Dis 1990; 141:179-85
24. Westlin WF, Gimbrone MA. Neutrophil-mediated damage to human vascular endothelium. Am J Pathol 1993; 142:117-28
25. Fujita J, Yamadori I, Kamei T, et al. Neutrophilic endotheliitis in patients with idiopathic pulmonary fibrosis [letter]. Chest 1995; 108:589
26. Crestani B, Seta N, Palazzo E, et al. Interleukin-8 and neutrophils in systemic sclerosis with lung involvement. Am J Respir Crit Care Med 1994;150:1363-67